Bottom line
MEDX vs FTXH: the short answer
MEDX (Horizon Kinetics Medical ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both etfs.
FTXH is cheaper at 0.6% vs 0.85% — a difference of $25 a year per $10,000 invested.
Over five years, FTXH returned +6.5% a year vs +5.8% for MEDX.
Updated Nov 19, 2026
MEDX vs FTXH side by side
| MEDX | FTXH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Roundhill | First Trust |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.85% | 0.6% |
| Annual cost per $10k | $85 | $60 |
| 10-yr cost on $10k (prospectus) | $1,049 | — |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +28.4% | +24.0% |
| 5-yr return (annualized) | +5.8% | +6.5% |
| 10-yr return (annualized) | +5.7% | — |
| Best quarter | +15.0% | +18.3% |
| Worst quarter | −12.9% | −17.4% |
| Net assets (fund) | $19.1M | $36.2M |
| Number of holdings | 33 | 51 |
| Portfolio turnover | % | 35% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MEDX | FTXH | Difference |
|---|---|---|---|
| 2025 | +28.4% | +24.0% | +4.4% |
| 2024 | −4.7% | +3.0% | −7.7% |
| 2023 | −6.0% | −1.4% | −4.6% |
| 2022 | +4.2% | +2.5% | +1.7% |
| 2021 | +10.6% | +6.1% | +4.5% |
| 2020 | +9.0% | +10.9% | −1.8% |
| 2019 | +16.0% | +22.4% | −6.3% |
| 2018 | +1.7% | −8.4% | +10.0% |
| 2017 | +10.7% | +18.8% | −8.1% |
Source: Fund prospectus bar charts
Holdings overlap
10 of MEDX's top 25 holdings also appear in FTXH's top 25.
| Holding | MEDX | FTXH |
|---|---|---|
| Eli Lilly & Co | 18.46% | 7.77% |
| AbbVie Inc | 8.85% | 7.39% |
| Johnson & Johnson | 5.59% | 6.96% |
| Alkermes PLC | 5.53% | 1.35% |
| Bristol-Myers Squibb Co | 4.42% | 6.29% |
| Merck & Co Inc | 3.96% | 7.07% |
| Amgen Inc | 3.91% | 3.18% |
| Biogen Inc | 3.09% | 3.84% |
| Pfizer Inc | 2.86% | 2.97% |
| Regeneron Pharmaceuticals Inc | 2.06% | 2.72% |
Source: SEC Form N-PORT
MEDX top 10
- Eli Lilly & Co — 18.46%
- US Bank Mmda - Usbgfs 7 — 9.19%
- AbbVie Inc — 8.85%
- Novartis AG — 6.89%
- Johnson & Johnson — 5.59%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Bristol-Myers Squibb Co — 4.42%
- Merck & Co Inc — 3.96%
FTXH top 10
- Eli Lilly & Company — 7.77%
- Abbvie Inc — 7.39%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Amgen Inc — 3.18%
FAQ
What is the difference between MEDX and FTXH?
Which is cheaper, MEDX or FTXH?
Should I own both MEDX and FTXH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.